Creative Biolabs Showcases Latest Neurological Disease Model Technologies at PPA Science & Technology Fair

May 08 22:30 2024
Creative Biolabs is set to showcase its latest innovations in neurological disease model technologies at the upcoming PPA Science & Technology Fair in Philadelphia on May 15, 2024.

New York, USA – May 8, 2024 – Creative Biolabs is poised to participate in the upcoming PPA Science & Technology Fair next week. A representative from Creative Biolabs stated, “We are eagerly looking forward to this upcoming event to share novel model technologies targeting neurological diseases.”

Neuroscience imaging has been employed to validate the conceptual interventions for Alzheimer’s disease. Besides, model technologies serve as accurate and reliable tools to expedite the discovery and development of neurological disease drugs. At Creative Biolabs, various animal models of the nervous system have been meticulously developed to mimic specific aspects of human neurological diseases, effectively identifying targets or studying disease progression.

“At this fair,” the representative explained, “our team will present detailed technical descriptions of some animal models, such as transgenic mouse models and rodent models of neurodegenerative diseases. This will be an excellent opportunity to interact with other researchers and professionals.”

Creative Biolabs’ animal model development for neurological diseases encompasses model design, development, and phenotype characterization, accurately summarizing animal models’ disease phenotypes to facilitate the discovery and validation of therapeutic targets.

“The causes of abnormal brain cell behavior in AD patients and the mechanisms underlying brain dysfunction have always been challenging, making Alzheimer’s disease mouse models highly significant.”

Another challenge in analyzing brain diseases is their prolonged course, with animal models often failing to capture key aspects of these diseases. “Therefore, Creative Biolabs will also showcase neural cell culture models for attendees and discuss how to apply this technology to their research projects.”

Such models developed by Creative Biolabs utilize in vitro methods, accelerating research into the pathological mechanisms of neurological diseases. For instance, neurodegenerative disease models, unlike in vivo animal models, can rapidly and directly display pathological changes.

Creative Biolabs also offers customized model development services to global clients. Attendees will have the opportunity to engage face-to-face with Creative Biolabs’ expert team to learn more about these innovative technologies.

For more information on Creative Biolabs’ neurological system model development, please visit https://www.creative-biolabs.com.

About Creative Biolabs

Creative Biolabs’ journey of participation this year will kick off at the PPA Science & Technology Fair, during which it will share its innovative therapeutic development technologies and strategies. Creative Biolabs aims to establish more collaborative relationships with researchers from various fields at the event, collectively advancing research on neurodegenerative diseases.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com